HIFU Prostate Services Expands Sales Team Adding Ross Boelsen as Vice President of Sales for the West Coast
CHARLOTTE, N.C., May 01, 2018 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC (HPS), the leading provider of HIFU technology to physician practices in the United States, is experiencing rapid growth and has added Ross Boelsen to its sales team as vice president of sales in the western region. Boelsen will be responsible for recruiting and educating new physicians to train with Sonablate® HIFU as well as help HIFU-trained doctors to expand their practice.
Prior to joining HIFU Prostate Services, Boelsen was a regional sales manager with VIDA Diagnostics. He has also held positions with NxThera, Medtronic, Intuitive Surgical and Applied Medical. Boelsen has worked in medical device sales and marketing for over 10 years and brings 20 years’ worth of overall sales experience to the company.
“We are delighted to have Ross join the HPS team. He comes highly recommended by several physicians that we work with closely,” said John Linn, chief executive officer of HIFU Prostate Services. “Ross has a proven track record of building relationships with leading urologists on the west coast to sell robots for Intuitive Surgical and Rezum, a BPH treatment, offered by NxThera.”
“I am excited to be joining the HIFU Prostate Services team to help expand the use of HIFU technology across the western region,” said Boelsen. “The HPS team has done an impressive job of bringing Sonablate® HIFU minimally invasive treatments to patients across the country. I look forward to working with physicians to continue to build awareness of the Sonablate® HIFU system for localized prostate cancer treatment.”
HIFU, which stands for high intensity focused ultrasound, is a non-surgical, radiation-free, outpatient procedure that uses focused sound waves to heat and destroy diseased tissue in the prostate gland. HIFU precisely focuses ultrasound energy to rapidly heat and destroy tissue in the prostate. Due to its accuracy and precision, areas around the prostate are undamaged which greatly reduces the risk of side effects such as urinary incontinence and erectile dysfunction.
In October 2015, the FDA cleared the Sonablate® technology for the ablation of prostatic tissue. Sonablate® HIFU leads the industry in prostate tissue ablation with features that monitor real-time changes in prostatic tissue during HIFU, detect the location of nerves responsible for preserving potency and keep the rectal wall from being damaged.
Last summer, a Medicare code was issued by the Centers for Medicare and Medicaid Services that may help some patients cover part of the cost of the HIFU procedure. Additional information about reimbursement may be found at https://www.hifuprostateservices.com/reimbursement.
About HIFU Prostate Services, LLC
HIFU Prostate Services was founded to provide men access to a less invasive treatment option for prostate cancer that has the ability to eliminate cancer and preserve patient quality of life. Our mission is to deliver the highest quality of care, support, and technology to the patient and to the urology community for the treatment of localized prostate cancer using Sonablate® HIFU. The company is headquartered in Charlotte, NC and with locations in 14 cities throughout the US. Learn more at http://www.hifuprostateservices.com.
Media Contact:
John Linn (704) 248-7562